Certara

Certara company information, Employees & Contact Information

Explore related pages

Related company profiles:

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.

Company Details

Employees
1.39K
Address
4 Radnor Corporate Center, Suite 350,france
Phone
(609)716-7900
Email
ma****@****ara.com
Industry
Business Consulting And Services
NAICS
Management, Scientific, and Technical Consulting Services
Management Consulting Services
Other Scientific and Technical Consulting Services
Other Management Consulting Services
HQ
Radnor, Pennsylvania
Looking for a particular Certara employee's phone or email?

Certara Questions

News

Certara, Inc. to Release Third Quarter 2025 Financial Results on November 6th - Quiver Quantitative

Certara, Inc. to Release Third Quarter 2025 Financial Results on November 6th Quiver Quantitative

Nov 6, 2025: Certara to Report Q3 2025 Results; Live webcast available on investor site - Stock Titan

Nov 6, 2025: Certara to Report Q3 2025 Results; Live webcast available on investor site Stock Titan

Pirana and Integrated PMX Tools, a Workbench for NONMEM, NLME, pyDarwin, and RsNLME - Wiley

Pirana and Integrated PMX Tools, a Workbench for NONMEM, NLME, pyDarwin, and RsNLME Wiley

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 - The Manila Times

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025 The Manila Times

Certara, Inc. Appoints Christopher Bouton, Ph.D., as Chief Technology Officer to Lead Next-Generation Drug Development Platform - Quiver Quantitative

Certara, Inc. Appoints Christopher Bouton, Ph.D., as Chief Technology Officer to Lead Next-Generation Drug Development Platform Quiver Quantitative

Certara Sets Q2 2025 Earnings Date: What Investors Need to Know About August 6 Results - Stock Titan

Certara Sets Q2 2025 Earnings Date: What Investors Need to Know About August 6 Results Stock Titan

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio - Yahoo Finance

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio Yahoo Finance

Certara - Technical.ly

Certara Technical.ly

Certara Introduces Pinnacle 21 Enterprise Plus to Enhance Clinical Data Specification Management | CERT Stock News - Quiver Quantitative

Certara Introduces Pinnacle 21 Enterprise Plus to Enhance Clinical Data Specification Management | CERT Stock News Quiver Quantitative

50% Time Reduction: Certara's New Pinnacle 21 Platform Transforms Clinical Data Submission Process - Stock Titan

50% Time Reduction: Certara's New Pinnacle 21 Platform Transforms Clinical Data Submission Process Stock Titan

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 - The Manila Times

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 The Manila Times

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions - citybiz

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions citybiz

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform - Yahoo Finance

Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform Yahoo Finance

Certara, Inc. to Release Second Quarter 2025 Financial Results on August 6th - Quiver Quantitative

Certara, Inc. to Release Second Quarter 2025 Financial Results on August 6th Quiver Quantitative

Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval - Wiley

Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval Wiley

Revolutionary AI Update: How Certara's New Simcyp Platform is Transforming Drug Development - Stock Titan

Revolutionary AI Update: How Certara's New Simcyp Platform is Transforming Drug Development Stock Titan

Critical Roles for Modeling and Simulation and Real‐World Evidence to Inform Challenges in Clinical Trial Diversity Planning - Kadambi - 2025 - Clinical and Translational Science - Wiley

Critical Roles for Modeling and Simulation and Real‐World Evidence to Inform Challenges in Clinical Trial Diversity Planning - Kadambi - 2025 - Clinical and Translational Science Wiley

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023 - Yahoo Finance

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023 Yahoo Finance

Certara, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - Quiver Quantitative

Certara, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 Quiver Quantitative

Comparison of dose selection based on target engagement versus inhibition of receptor–ligand interaction for checkpoint inhibitors - Wiley

Comparison of dose selection based on target engagement versus inhibition of receptor–ligand interaction for checkpoint inhibitors Wiley

Certara to Participate in Upcoming Investor Conferences - Stock Titan

Certara to Participate in Upcoming Investor Conferences Stock Titan

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase - Yahoo Finance

Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase Yahoo Finance

A.I. Coming to Certara’s D360 Scientific Informatics Software - Yahoo Finance

A.I. Coming to Certara’s D360 Scientific Informatics Software Yahoo Finance

Certara Acquires Applied BioMath - citybiz

Certara Acquires Applied BioMath citybiz

A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator - Wiley

A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator Wiley

Certara, Inc. Reports Preliminary Full-Year 2024 Revenue of $384.4 Million and Bookings of $445.3 Million - Quiver Quantitative

Certara, Inc. Reports Preliminary Full-Year 2024 Revenue of $384.4 Million and Bookings of $445.3 Million Quiver Quantitative

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation - Yahoo Finance

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation Yahoo Finance

11 Certara Scientists on Stanford/Elsevier Top Cited List; Company Publishes 200+ Papers in Past Year - Stock Titan

11 Certara Scientists on Stanford/Elsevier Top Cited List; Company Publishes 200+ Papers in Past Year Stock Titan

QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation - Wiley

QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation Wiley

Another Step Toward Qualification of Pediatric Physiologically Based Pharmacokinetic Models to Facilitate Inclusivity and Diversity in Pediatric Clinical Studies - Wiley

Another Step Toward Qualification of Pediatric Physiologically Based Pharmacokinetic Models to Facilitate Inclusivity and Diversity in Pediatric Clinical Studies Wiley

Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform - Lab Manager

Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform Lab Manager

Mechanistic Model for Drug Release from PLGA-Based Biodegradable Implants for In Vitro Release Testing: Development and Validation - ACS Publications

Mechanistic Model for Drug Release from PLGA-Based Biodegradable Implants for In Vitro Release Testing: Development and Validation ACS Publications

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year - Stock Titan

Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year Stock Titan

Hepatic OATP1B zonal distribution: Implications for rifampicin-mediated drug–drug interactions explored within a PBPK framework - Wiley

Hepatic OATP1B zonal distribution: Implications for rifampicin-mediated drug–drug interactions explored within a PBPK framework Wiley

Evaluation of covariate effects using forest plots and introduction to the coveffectsplot R package - Wiley

Evaluation of covariate effects using forest plots and introduction to the coveffectsplot R package Wiley

Certara Launches Version 8.0 of its Industry-leading Phoenix® PK/PD Modeling and Simulation Software for Drug Development Scientists - Lab Manager

Certara Launches Version 8.0 of its Industry-leading Phoenix® PK/PD Modeling and Simulation Software for Drug Development Scientists Lab Manager

Certara Appoints Drayton T. Virkler as Chief Commercial Officer - Yahoo Finance

Certara Appoints Drayton T. Virkler as Chief Commercial Officer Yahoo Finance

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Sixth Consecutive Year - Business Wire

Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for Sixth Consecutive Year Business Wire

Translational Population-Pharmacodynamic Modeling of a Novel Long-Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia - Wiley

Translational Population-Pharmacodynamic Modeling of a Novel Long-Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia Wiley

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 - 富途牛牛

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 富途牛牛

Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution - Lab Manager

Certara Announces the Availability of PK Submit, its Pharmacokinetic CDISC Technology Solution Lab Manager

Certara experts highlight quantitative systems pharmacology's role in first-in-human clinical trials - EurekAlert!

Certara experts highlight quantitative systems pharmacology's role in first-in-human clinical trials EurekAlert!

Certara Introduces Externalization Technology to Its D360 Scientific Informatics Platform - Lab Manager

Certara Introduces Externalization Technology to Its D360 Scientific Informatics Platform Lab Manager

Certara Launches Version 17 of Its PBPK Simcyp Simulator - Lab Manager

Certara Launches Version 17 of Its PBPK Simcyp Simulator Lab Manager

Certara Announces Acquisition Of Brighton's Great Lakes Drug Development - CBS News

Certara Announces Acquisition Of Brighton's Great Lakes Drug Development CBS News

Arsenal Acquires Synchrogenix - Private Equity Professional

Arsenal Acquires Synchrogenix Private Equity Professional

Top Certara Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant